Patents by Inventor Steve Chappell Mitchell

Steve Chappell Mitchell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020150972
    Abstract: A novel gene (designated 34P3D7) and its encoded protein are described. While 34P3D7 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed multiple cancers including prostate, bladder, kidney, brain, bone, cervical, uterine, ovarian, breast, pancreatic, stomach, colon, rectal, leukocytic, liver and lung cancers. Consequently, 34P3D7 provides a diagnostic and/or therapeutic target for cancers, and the 34P3D7 gene or fragment thereof, or its encoded protein or a fragment thereof used to elicit an immune response.
    Type: Application
    Filed: February 8, 2001
    Publication date: October 17, 2002
    Inventors: Mary Faris, Daniel E.H. Afar, Pia M. Challita-Eid, Rene S. Hubert, Elana Levin, Steve Chappell Mitchell, Aya Jakobovits
  • Publication number: 20020102640
    Abstract: A novel gene (designated 83P5G4) and its encoded protein are described. Whereas 83P5G4 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed multiple cancers including prostate, testicular, bladder, kidney, brain, bone, cervical, uterine, ovarian, breast, pancreatic, stomach, colon, rectal, leukocytic, liver and lung cancers. Consequently, 83P5G4 provides a diagnostic and/or therapeutic target for cancers, and the 83P5G4 gene or fragment thereof, or its encoded protein or a fragment thereof used to elicit an immune response.
    Type: Application
    Filed: February 9, 2001
    Publication date: August 1, 2002
    Inventors: Rene S. Hubert, Daniel E.H. Afar, Pia M. Challita-Eid, Mary Faris, Elana Levin, Steve Chappell Mitchell, Aya Jakobovits
  • Publication number: 20020068345
    Abstract: A novel gene (designated 98P7C3) and its encoded protein are described. While 98P7C3 exhibits tissue-restricted expression in normal adult tissue, it is aberrantly expressed in multiple cancers including prostate, bladder, kidney, lung, breast, uterine, cervical, stomach, rectal and colon cancers. Consequently, 98P7C3 provides a diagnostic and/or therapeutic target for cancers, and the 98P7C3 gene or fragment thereof, or its encoded protein or a fragment thereof used to elicit an immune response.
    Type: Application
    Filed: May 24, 2001
    Publication date: June 6, 2002
    Inventors: Pia M. Challita-Eid, Rene S. Hubert, Mary Faris, Daniel E.H. Afar, Elana Levin, Steve Chappell Mitchell, Aya Jakobovits
  • Publication number: 20020055478
    Abstract: A novel gene (designated 103P3E8) and its encoded protein are described. While 103P3E8 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including prostate, bladder, kidney, colon, lung, breast, rectal and stomach cancers. Consequently, 103P3E8 provides a diagnostic and/or therapeutic target for cancers, and the 103P3E8 gene or fragment thereof, or its encoded protein or a fragment thereof can be used to elicit an immune response.
    Type: Application
    Filed: April 12, 2001
    Publication date: May 9, 2002
    Inventors: Mary Faris, Pia M. Challita-Eid, Arthur B. Raitano, Steve Chappell Mitchell, Daniel E.H. Afar, Aya Jakobovits